Related Experiment Video
Updated: Jul 11, 2025

05:46
Ultrasonic-Assisted Extraction of Cannabidiolic Acid from Cannabis Biomass
Published on: May 27, 2022
6.2K
A Continuing Pharmacy Education (CPE) Program Assessing Cannabidiol (CBD) Knowledge and Confidence Among Practicing
Sarah E Farmer1, John A Arnold1, Peter J Hughes1
1McWhorter School of Pharmacy, Samford University, Birmingham, AL, USA.
Journal of Pharmacy Practice
|November 7, 2023
Summary
Pharmacists
Area of Science:
- Pharmacology and Pharmaceutical Sciences
- Continuing Pharmacy Education
Background:
- Growing patient use of cannabidiol (CBD) necessitates pharmacist knowledge on potential drug interactions and product safety.
- Addressing the knowledge gap among pharmacists regarding CBD is crucial for patient care.
Purpose of the Study:
- To evaluate the existing knowledge gap in pharmacists concerning CBD and its products.
- To assess the impact of a continuing pharmacy education (CPE) program on pharmacist confidence and competency in CBD knowledge.
Main Methods:
- A 1-hour home-study CPE activity was conducted from May to September 2022.
- Practicing pharmacy preceptors in Alabama completed pre- and post-surveys for matched-pair analysis.
- Knowledge improvement and self-rated confidence in counseling, answering drug information, and ensuring patient safety were primary and secondary outcome measures.
Main Results:
- Participant knowledge scores significantly improved from 50.0% to 87.8% (P < .001) after the CPE program.
- Pharmacist confidence in counseling patients, answering healthcare professional queries, and ensuring patient safety regarding CBD significantly increased (average Likert scale increase of ~1.7; P < .001).
- 124 participants completed the course, with 64 and 56 included in knowledge and confidence analyses, respectively.
Conclusions:
- A targeted CPE program effectively enhanced pharmacists' knowledge of CBD.
- The educational intervention led to increased pharmacist competency in counseling patients and ensuring safety concerning CBD products.
- Improved pharmacist knowledge and confidence are vital for managing the implications of increasing CBD utilization.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
286
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
286
Drug Administration and Therapy Phases: Overview
483
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
483
Pharmacovigilance
860
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
860
Drug Concentrations: Measurements
379
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
Plasma...
379
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Drug Control Governance: Regulatory Bodies and Their Impact
163
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
163

